Orchid Pharma Limited (ORCHPHARMA) - Total Liabilities
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has total liabilities worth Rs6.23 Billion INR (≈ $67.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ORCHPHARMA financial resilience to evaluate the company's liquid asset resilience ratio.
Orchid Pharma Limited - Total Liabilities Trend (2004–2026)
This chart illustrates how Orchid Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Orchid Pharma Limited.
Orchid Pharma Limited Competitors by Total Liabilities
The table below lists competitors of Orchid Pharma Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Elior SCA
PA:ELIOR
|
France | €2.91 Billion |
|
Puradelta Lestari PT
JK:DMAS
|
Indonesia | Rp408.98 Billion |
|
Mediterranean Towers Ltd
TA:MDTR
|
Israel | ILA5.15 Billion |
|
Nextdoor Holdings Inc
NYSE:KIND
|
USA | $60.82 Million |
|
Beyond, Inc.
NASDAQ:BYON
|
USA | $226.87 Million |
|
Mega-info Media Co.Ltd.
SHE:301102
|
China | CN¥919.88 Million |
|
Kforce Inc.
NASDAQ:KFRC
|
USA | $242.03 Million |
|
Alltop Technology Co Ltd
TWO:3526
|
Taiwan | NT$4.82 Billion |
Liability Composition Analysis (2004–2026)
This chart breaks down Orchid Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Orchid Pharma Limited's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orchid Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orchid Pharma Limited (2004–2026)
The table below shows the annual total liabilities of Orchid Pharma Limited from 2004 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs6.23 Billion ≈ $67.39 Million |
+48.14% |
| 2025-03-31 | Rs4.21 Billion ≈ $45.49 Million |
+9.42% |
| 2024-03-31 | Rs3.84 Billion ≈ $41.57 Million |
-28.36% |
| 2023-03-31 | Rs5.37 Billion ≈ $58.03 Million |
+15.84% |
| 2022-03-31 | Rs4.63 Billion ≈ $50.09 Million |
-20.73% |
| 2021-03-31 | Rs5.84 Billion ≈ $63.19 Million |
-15.79% |
| 2020-03-31 | Rs6.94 Billion ≈ $75.04 Million |
-81.65% |
| 2019-03-31 | Rs37.81 Billion ≈ $408.91 Million |
-3.47% |
| 2018-03-31 | Rs39.17 Billion ≈ $423.62 Million |
+5.23% |
| 2017-03-31 | Rs37.22 Billion ≈ $402.56 Million |
-2.38% |
| 2016-03-31 | Rs38.13 Billion ≈ $412.36 Million |
+2.17% |
| 2015-03-31 | Rs37.32 Billion ≈ $403.60 Million |
-12.61% |
| 2013-03-31 | Rs42.70 Billion ≈ $461.83 Million |
+52.35% |
| 2012-03-31 | Rs28.03 Billion ≈ $303.13 Million |
-6.55% |
| 2011-03-31 | Rs29.99 Billion ≈ $324.37 Million |
+5.76% |
| 2010-03-31 | Rs28.36 Billion ≈ $306.69 Million |
-21.23% |
| 2009-03-31 | Rs36.00 Billion ≈ $389.34 Million |
+27.70% |
| 2008-03-31 | Rs28.19 Billion ≈ $304.89 Million |
+17.18% |
| 2007-03-31 | Rs24.06 Billion ≈ $260.19 Million |
+72.72% |
| 2006-03-31 | Rs13.93 Billion ≈ $150.64 Million |
+3.05% |
| 2005-03-31 | Rs13.52 Billion ≈ $146.18 Million |
+32.85% |
| 2004-03-31 | Rs10.17 Billion ≈ $110.03 Million |
-- |
About Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more